Zobrazeno 1 - 3
of 3
pro vyhledávání: '"K B Kristoffersen"'
Autor:
N. Mikic, F. R. Poulsen, K. B. Kristoffersen, R. J. Laursen, T. L. Guldberg, J. Skjøth-Rasmussen, E. T. Wong, S. Møller, R. H. Dahlrot, J. C. H. Sørensen, A. R. Korshøj
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background OptimalTTF-2 is a randomized, comparative, multi-center, investigator-initiated, interventional study aiming to test skull remodeling surgery in combination with Tumor Treating Fields therapy (TTFields) and best physicians choice
Externí odkaz:
https://doaj.org/article/fda3c01df1be447291f0b6181f7e7e9e
Publikováno v:
Neuro-Oncology. 24:ii57-ii58
Background Stereotactic radiosurgery (SRS) is preferred to whole brain radiotherapy (WBRT) for the treatment of patients with a limited number of brain metastases, both as primary treatment and after surgery. SRS can be delivered in a single fraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecaed88f2e1cfa711687433c4a479f63
https://doi.org/10.1093/neuonc/noac174.200
https://doi.org/10.1093/neuonc/noac174.200
Autor:
A. R. Korshøj, Frantz Rom Poulsen, Nikola Mikic, Eric T. Wong, Jane Skjøth-Rasmussen, K. B. Kristoffersen, Jens Christian Sørensen, Trine Lignell Guldberg, Susanne Møller, Rikke Hedegaard Dahlrot, R. J. Laursen
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Mikic, N, Poulsen, F R, Kristoffersen, K B, Laursen, R J, Guldberg, T L, Skjøth-Rasmussen, J, Wong, E T, Møller, S, Dahlrot, R H, Sørensen, J C H & Korshøj, A R 2021, ' Study protocol for OptimalTTF-2 : enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial ', BMC Cancer, vol. 21, 1010 . https://doi.org/10.1186/s12885-021-08709-4
Mikic, N, Poulsen, F R, Kristoffersen, K B, Laursen, R J, Guldberg, T L, Skjøth-Rasmussen, J, Wong, E T, Møller, S, Dahlrot, R H, Sørensen, J C H & Korshøj, A R 2021, ' Study protocol for OptimalTTF-2 : enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial ', BMC Cancer, vol. 21, no. 1, 1010 . https://doi.org/10.1186/s12885-021-08709-4
BMC Cancer
Mikic, N, Poulsen, F R, Kristoffersen, K B, Laursen, R J, Guldberg, T L, Skjøth-Rasmussen, J, Wong, E T, Møller, S, Dahlrot, R H, Sørensen, J C H & Korshøj, A R 2021, ' Study protocol for OptimalTTF-2 : enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial ', BMC Cancer, vol. 21, 1010 . https://doi.org/10.1186/s12885-021-08709-4
Mikic, N, Poulsen, F R, Kristoffersen, K B, Laursen, R J, Guldberg, T L, Skjøth-Rasmussen, J, Wong, E T, Møller, S, Dahlrot, R H, Sørensen, J C H & Korshøj, A R 2021, ' Study protocol for OptimalTTF-2 : enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial ', BMC Cancer, vol. 21, no. 1, 1010 . https://doi.org/10.1186/s12885-021-08709-4
BMC Cancer
Background OptimalTTF-2 is a randomized, comparative, multi-center, investigator-initiated, interventional study aiming to test skull remodeling surgery in combination with Tumor Treating Fields therapy (TTFields) and best physicians choice medical o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d48953422953d13fc520feb8c077d44
https://doi.org/10.1186/s12885-021-08709-4
https://doi.org/10.1186/s12885-021-08709-4